Health
US vaccine hopeful of using Gates Foundation cash to prepare for human trial – Hindustan Times
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their Covid-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage.
“We believe there is real potential,” Vandenberghe…
-
Noosa News14 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
Business19 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
General16 hours agoAustralia’s native flora emerges as an increasingly popular muse for bonsai hobbyists
-
Noosa News19 hours agoOn your marks, get set, buy!